---
title: "BioCryst Pharma (BCRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BCRX.US/norm.md"
symbol: "BCRX.US"
name: "BioCryst Pharma"
parent: "https://longbridge.com/en/quote/BCRX.US.md"
datetime: "2026-05-21T05:55:18.972Z"
locales:
  - [en](https://longbridge.com/en/quote/BCRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BCRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BCRX.US/norm.md)
---

# BioCryst Pharma (BCRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.98 | 1.13 | 0.0600 | 0.0200 | 0.0001 |
| ROE | 858.03% | -387.89% | -12.75% | -4.66% | -0.03% |
| Revenue | 156.41M | 406.56M | 159.40M | 163.35M | 145.53M |
| Net income | -721.81M | 245.84M | 12.90M | 5.08M | 32000.00 |
| Operating income | -3.84M | 266.70M | 29.59M | 29.79M | 21.23M |
| Gross margin | 58.00% | 88.11% | 70.65% | 71.73% | 71.25% |
| Net margin | -461.48% | 60.47% | 8.09% | 3.11% | 0.02% |
| Profit quality | - | 91.35% | 71.09% | 72.12% | -77.14% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 465.05M | 514.16M | 446.42M | 457.19M | 480.05M |
| Leverage | -0.8397 | -4.32 | -1.15 | -1.08 | -1.06 |
| BVPS | -2.18 | -0.5592 | -1.84 | -2.01 | -2.16 |
| Turnover | 1.87 | 1.74 | 1.28 | 1.20 | 1.06 |
| Cash & STI | 238.40M | 274.75M | 212.87M | 260.04M | 295.09M |
| Inv & Rec | 5.99M | 5.40M | 5.23M | 5.04M | 6.87M |
| LT assets | 22.98M | 18.99M | 19.24M | 20.00M | 19.57M |
| Net debt | 619.68M | 202.58M | 470.24M | 478.88M | 534.20M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -61.79M | 291.96M | 41.62M | 41.30M | -27.52M |
| Investing CF | -268.65M | -83.49M | 13.57M | 29.13M | 27.09M |
| Financing CF | 412.55M | -217.96M | -58.81M | -73.69M | 529000.00 |
| Free CF | 4.99M | 208.96M | 44.70M | 53.26M | -652125.00 |
| OCF coverage | -5048.28% | 147.50% | 66.92% | 54.04% | -4175.57% |
| Repaid & issued | 400.00M | - | - | - | - |
| CapEx | -403000.00 | -802000.00 | -1.34M | -179000.00 | -143000.00 |